TriSalus Life Sciences Statistics
NASDAQ: TLSIHealthcareMedical DevicesUSD
4.13-0.12 (-2.82%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
TriSalus Life Sciences by the numbers
TriSalus Life Sciences has a market capitalization of $254.3 million based on 61.57M shares outstanding. With trailing EPS of $-1.22, TriSalus Life Sciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 15.4% below its 50-day average and 10.5% below its 200-day average.
Average daily trading volume is 275.38K shares, or about $1.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
TLSI valuation vs. peer median
| Metric | TLSI | Peer median | Difference |
|---|---|---|---|
| Market cap | $254.30M | $92.58M | +175% |
| Avg. volume | 275.38K | 302.49K | -9% |
Peer median across 8 companies: LUCD, MXCT, HYPR, APYX, ECOR, SERA, LNSR, LUNG.
Valuation
- Market cap
- $254.30M
- EPS (TTM)
- $-1.22
- Shares outstanding
- 61.57M
Price and trading
- Previous close
- 4.25
- Open
- 4.13
- Day range
- 4.02 – 4.14
- 52-week range
- 2.20 – 7.95
- 52-week change
- -14.85%
- Beta
- —
- Volume
- 275.54K
- Average volume
- 275.38K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 6, 2026
Additional statistics
- Market Cap
- 254.30M
- Forward Pe
- -16.52
- Eps
- -1.22
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 7.95
- Week52 Low
- 2.20
- Avg Volume
- 275.38K
- Shares Outstanding
- 61.57M
- Ma50
- 4.88
- Ma200
- 4.61
- Earnings Date
- Aug 6, 2026
- Pct From52w High
- -48.05%
- Pct From52w Low
- 87.73%